Overview

 

The Antimicrobial MicroClave needlefree connector contains silver that is impregnated into both the split septum silicone seal and internal blunt cannula, which provides an even and continuous distribution of silver ions. Silver escapes into all areas surrounding the silicone including the internal fluid path and area between the silicone and housing.

The design of your needlefree intravenous (IV) connectors plays a substantial role in your ability limit hospital-acquired bloodstream infections (HA-BSI).2 During the production process, ionic silver is integrated into both the split-septum and internal fluid path for a continuous 96-hour use life. Not only does the Antimicrobial MicroClave provide enhanced patient safety through innovative technology, but it has also been proven to provide an effective microbial barrier against bacteria transfer and contamination.3,4

Additional Features:

  • The Antimicrobial MicroClave can be used on all peripheral, arterial, and central venous catheters for the administration of IV fluids or medications, and can be used with blood products and power injectors. 

  • Does not require a change in clinical practice or technique and may help you address recent concerns raised by the FDA regarding the safety of positive displacement connectors.5

Antimicrobial MicroClave  | Neutral Displacement Connector

How it works

Unique features of the Antimicrobial MicroClave that may help reduce the risk of bacterial contamination:

  • Ionic silver additive is integrated into both the split-septum and internal fluid path for a continuous 96-hour use life.

  • Split-septum is noted in the CDC draft guidelines as a preferred design feature for connectors.6

  • Straight fluid path allows for clearing of blood and blood residual with low flush volumes.7

  • Minimal deadspace (also referred to as residual volume) of 0.04 mL allows for lower flush volumes.

  • Flat smooth swabable surface for ease of disinfection.

  • Approved for use with power injectors.

BFstroke-thumb.pngCompare Flushing Efficiencies
of Needlefree Connectors

Ag-MicroClave-Diagram.png
 

Accessing the Fluid Path

  1. When Antimicrobial MicroClave is not being accessed, the silicone seal forms a safe, swabbable barrier to bacterial ingress.

  2. Upon luer access, the silicone seal is depressed and the fluid path windows are exposed through the device's split septum.

  3. Fluid is either infused or aspirated through the connector and catheter via the dedicated straight internal fluid path.

AgMicroClave-3-Step1.png
 

Technical Specifications

Residual Volume: 0.04 mL
 
Flow Rate at Gravity: 165 mL / minute
 
Functional Activations: 600
 
Blood Compatibility: Yes
 
MRI Compatibility: Yes
 
High Pressure Compatibility: 10 mL / second
 

Drug Compatibility

Alcohol: Yes
 
Lipids: Yes
 
Chlorhexidine: Yes
 
Chemotherapy: Yes
 
 

Educational Seminars & Presentations

Needle Free Connectors

Needle-free Connectors: Split Septum vs. Mechanical Valve…Can this classification model predict infection risk? By Marcia Ryder, PhD MS RN. APIC 2010 Satellite Symposium, Tuesday, July 13th, 2010. Running time: 1hr. 27min.
Click Here to View the Seminar >

 

References

  1. Antimicrobial efficacy of the MicroClave Connector using silver-saturated fluid path elements M1-1251 Rev. 1. Data on file at ICU Medical. 
  2. Jarvis W., MD. Choosing the Best Design for Intravenous Needleless Connectors to Prevent Bloodstream Infections. Infection Control Today, August 2010.View >
  3. Ryder M, RN, PhD. Bacterial transfer through needlefree connectors: Comparison of nin different devices. Poster presented at the Annual Society for Healthcare Epidemiology of America (SHEA) conference 2007, Abstract 412.
  4. Moore C, RN, MBA, CIC. Maintained Low Rate of Catheter-Related Bloodstream Infections (CR-BSIs) After Discontinuation of a Luer Access Device (LAD) At an Academic Medical Center. Poster presented at the annual Association for Professionals in Infection Control and Epidemiology (APIC) Conference 2010, Abstract 4-028.View >
  5. FDA Medical Device Safety Alert, July 28, 2010: Letter to Infection Control Practitioners Regarding Positive Displacement Needleless Connectors View >
  6. Guideline for the Prevention of Intravascular Catheter-Related Bloodstream Infections, Final Issue Review, May 17, 2010 View >
  7. Data on file at ICU Medical. Low Volume Flush Characteristics of Unique Needlefree Connectors M1-1223 Rev. 1.

 

Publications



Clinical Reports



Product Reference

Print

Disinfect to Protect

  • When placing a new Antimicrobial MicroClave on a catheter, disinfect the catheter hub and prime the Antimicrobial MicroClave.
  • Before accessing a Antimicrobial MicroClave, always disinfect the injection site with the approved antiseptic per facility protocol.
  • Scrub the injection site in accordance with facility protocol for appropriate scrubbing and dry times.

Disinfect to Protect

Administer or Aspirate

  • Attach IV tubing, syringe or blood tube holder to Antimicrobial MicroClave by inserting the luer and twisting ¼ turn, or until a friction fit is achieved.
  • Do not over-tighten a luer beyond the friction fit as this may damage both the luer and the Antimicrobial MicroClave.
  • To disconnect, grasp Antimicrobial MicroClave and then twist the mating luer counterclockwise away from Antimicrobial MicroClave until loose. Do not hold catheter hub during disconnect as this may cause accidental removal of Antimicrobial MicroClave from hub.

Administer or Aspirate

Flush After Each Use

  • Flush the Antimicrobial MicroClave with normal saline or in accordance with facility protocol. After blood use, the Antimicrobial MicroClave can be flushed clean and does not require change-out.
  • Use routine flushing in accordance with facility protocol in order to maintain catheter patency.
  • Change Antimicrobial MicroClave in accordance with facility protocol and CDC guidelines.

Flush After Each Use